Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
324
324 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
Genelux Corporation · Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer
- S095018Phase 21 trial
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)
- S095024Phase 21 trial
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)
- SL-28Phase 21 trial
Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic
- SNB-101Phase 21 trial
SN BioScience · Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC)
- ST-067Phase 21 trial
Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma
- STK-012Phase 21 trial
Synthekine · Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC
- STX-241PFL-241Phase 21 trial
Pierre Fabre Medicament · Non-small Cell Lung Cancer (NSCLC)
- STX-721PFL-721, EscalatedPhase 21 trial
Pierre Fabre Medicament · Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation
- TAS0953HM06Phase 21 trial
Taiho Pharmaceutical Co., Ltd. · RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors
- TH9619Phase 21 trial
One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck
- TNG260Phase 21 trial
Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Solid Tumors, Adult, Lung Cancer
- TNG456Phase 21 trial
Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme, Glioma, Malignant
- TRI-611Phase 21 trial
TRIANA Biomedicines, Inc. · ALK-positive NSCLC, ALK-Positive Lung Cancer, ALK-positive Non-small Cell Lung Cancer
- TT-10Phase 21 trial
Portage Biotech · Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer
- TXN10128Phase 21 trial
Txinno Bioscience Inc. · NSCLC (Non-small Cell Lung Cancer)
- VLS-1488Phase 21 trial
Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer
- VMD-928Phase 21 trial
VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer
- VRN110755Phase 21 trial
Voronoi, Inc · EGFR-Mutant Non-Small Cell Lung Cancer
- WEF-001Phase 21 trial
Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer
- XTX501Phase 21 trial
Xilio Development, Inc. · Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced Solid Tumor
- XYA02Phase 21 trial
XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer
- XZP-5955Phase 21 trial
Xuanzhu Biopharmaceutical Co., Ltd. · Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- YH42946Phase 21 trial
Yuhan Corporation · NSCLC (Non-small Cell Lung Cancer), Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.